Literature DB >> 17978293

Leukotrienes.

Marc Peters-Golden1, William R Henderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17978293     DOI： 10.1056/NEJMra071371

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  338 in total

1.  Intrapulmonary administration of leukotriene B(4) augments neutrophil accumulation and responses in the lung to Klebsiella infection in CXCL1 knockout mice.

Authors:  Sanjay Batra; Shanshan Cai; Gayathriy Balamayooran; Samithamby Jeyaseelan
Journal:  J Immunol       Date:  2012-02-29       Impact factor: 5.422

2.  Regulation of oxidative stress and inflammation by glycaemic control: evidence for reversible activation of the 5-lipoxygenase pathway in type 1, but not in type 2 diabetes.

Authors:  R Boizel; G Bruttmann; P Y Benhamou; S Halimi; F Stanke-Labesque
Journal:  Diabetologia       Date:  2010-06-10       Impact factor: 10.122

3.  Seeing the future of bioactive lipid drug targets.

Authors:  Jilly F Evans; John H Hutchinson
Journal:  Nat Chem Biol       Date:  2010-07       Impact factor: 15.040

4.  Molecular pharmacological profile of a novel thiazolinone-based direct and selective 5-lipoxygenase inhibitor.

Authors:  B Hofmann; C B Rödl; A S Kahnt; T J Maier; A A Michel; M Hoffmann; O Rau; K Awwad; M Pellowska; M Wurglics; M Wacker; A Zivković; I Fleming; M Schubert-Zsilavecz; H Stark; G Schneider; D Steinhilber
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

5.  Increased expression of leukotriene C4 synthase and predominant formation of cysteinyl-leukotrienes in human abdominal aortic aneurysm.

Authors:  Antonio Di Gennaro; Dick Wågsäter; Mikko I Mäyränpää; Anders Gabrielsen; Jesper Swedenborg; Anders Hamsten; Bengt Samuelsson; Per Eriksson; Jesper Z Haeggström
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

6.  Small β2-glycoprotein I peptides protect from intestinal ischemia reperfusion injury.

Authors:  Michael R Pope; Urska Bukovnik; John M Tomich; Sherry D Fleming
Journal:  J Immunol       Date:  2012-10-03       Impact factor: 5.422

Review 7.  Pharmacogenetics of asthma.

Authors:  John J Lima; Kathryn V Blake; Kelan G Tantisira; Scott T Weiss
Journal:  Curr Opin Pulm Med       Date:  2009-01       Impact factor: 3.155

Review 8.  Antileukotrienes in upper airway inflammatory diseases.

Authors:  Cemal Cingi; Nuray Bayar Muluk; Kagan Ipci; Ethem Şahin
Journal:  Curr Allergy Asthma Rep       Date:  2015-11       Impact factor: 4.806

9.  Inhibition of 5-lipoxygenase decreases renal fibrosis and progression of chronic kidney disease.

Authors:  John R Montford; Colin Bauer; Evgenia Dobrinskikh; Katharina Hopp; Moshe Levi; Mary Weiser-Evans; Raphael Nemenoff; Seth B Furgeson
Journal:  Am J Physiol Renal Physiol       Date:  2019-01-16

10.  Leukotriene B4 enhances innate immune defense against the puerperal sepsis agent Streptococcus pyogenes.

Authors:  Elyara M Soares; Katie L Mason; Lisa M Rogers; Carlos H Serezani; Lucia H Faccioli; David M Aronoff
Journal:  J Immunol       Date:  2013-01-16       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.